The U.S. Food and Drug Administration (FDA) on Tuesday paused its marketing denial order on Juul e-cigarettes while it carries out a review into “scientific issues” unique to the company’s application.
“On July 5, 2022, FDA administratively stayed the marketing denial order. This administrative stay temporarily suspends the marketing denial order during the additional review but does not rescind it,” the FDA announced on Twitter.
“All electronic nicotine delivery systems, or ENDS products, including those made by JUUL, are required by law to have FDA authorization to be legally marketed. The stay and the agency’s review does not constitute authorization to market, sell, or ship JUUL products.”…